Category: Joint ventures/collaborations
-
A.I. Discovery Companies to Find Rare Disease Drugs
A joint venture of two drug discovery and design companies aims to create new biotechnology businesses to find drugs for treating rare diseases.
-
Guidelines Proposed for Complex Clinical Trials
A working group published guidelines for conducting clinical trials that simultaneously test multiple cancer treatments and can change course over time.
-
Touch Sensor Developer Gains $12M in Early Funds
A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round.
-
Engineered Viruses Licensed for Cancer Therapies
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals.
-
Duke Univ Forms Drug Development Company
Duke University and life science investor Deerfield Management are forming a new enterprise to develop drug candidates through early development stages.
-
Supermarkets to Offer Genetic Mental Health Test
A chain of supermarket pharmacies in Pennsylvania will begin offering genetic tests to help customers manage their mental health medications.
-
Rice Univ, Shell Partner on Sustainable Carbon
Rice University and the energy company Shell launched a program to sustainably produce carbon derived from splitting rather than burning hydrocarbons.
-
Broad Inst, Biotech Partner on Immune-Safe Crispr
A company designing synthetic proteins and the Broad Institute are developing ways to reduce the threat of edited genes producing an immune-system response.
-
Nature, Merck Establish Science Entrepreneur Prize
The scientific publisher Springer Nature and drug maker Merck are creating an annual award for early-stage companies spun-off from academic research.
-
Biotech Licenses Gene-Limiting Technology for Allergies
A biotechnology company developing treatments for skin conditions is acquiring a technology for limiting effects of genes causing asthma and allergic reactions.